Debra A. Kendall

Also affiliated with Virginia Commonwealth University, Texas College, Texas A&M University

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5”.

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5

Journal of Pharmacological Sciences(2020)10.1016/j.jphs.2020.12.006

N/A

0DataRank · unranked

10 citations

Barbara Wolk, Stevie C. Britch, Rebecca M. Craft, Debra A. Kendall, Yaliang Tang

Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex: Computational Analysis of the CB1 Carboxyl-Terminus

UNC Libraries(2020)10.17615/9nfe-v283

N/A

0DataRank · unranked

0 citations

Leepakshi Khurana, Debra A. Kendall, Joong‐Youn Shim

The Cannabinoid Receptor Type 1 Positive Allosteric Modulator ZCZ011 Attenuates Naloxone-Precipitated Diarrhea and Weight Loss in Oxycodone-Dependent Mice

Journal of Pharmacology and Experimental Therapeutics(2021)10.1124/jpet.121.000723

N/A

0DataRank · unranked

15 citations

Rebecca K. Moncayo, M. Imad Damaj, Joel E. Schlosburg, Hamid I. Akbarali, Lesley D. Schurman +5 more

Characterization of Subtype Selective Cannabinoid CB2 Receptor Agonists as Potential Anti-Inflammatory Agents

Pharmaceuticals(2021)10.3390/ph14040378

N/A

0DataRank · unranked

3 citations

Barbara Wolk, Ryan Nolan, Caitlin E. Scott, Debra A. Kendall, Yaliang Tang